Skip to main content

Nifty +0.2% but internals keep deteriorating

Decliners beat advancers 1,554 to 918; net new highs just turned negative. This is not a dip inside strength.

Thursday, 10 September 20262 min readStage2Stocks Market Desk

Nifty 50
23,478
+0.2% on the day
Market
Neutral — Fading
8 sessions in this state
Breadth
41%
above 200-DMA · narrow
Adv / Dec
918 / 1,554
decliners ahead
52w highs / lows
171 / 185
net -14
Stage-2 share
33%
cohort narrowing

Today's 0.2% bounce in Nifty 50 is a dead-cat flicker, not a turn. Decliners beat advancers 1,554 to 918, net new highs flipped to -14, and the fast breadth gauge has now dropped five of the last six sessions — the index is holding up better than the market beneath it. This is a deteriorating tape in transition, not a dip inside an uptrend worth leaning into.

Trajectory: the internals are getting worse, not better

The slow structural gauge — the share of stocks above their 200-day average — has slid from 42.4 to 41.3 over the past week, a quiet but steady erosion. The fast short-term gauge has fallen harder, from 43.7 on 4 September to 39.0 today, confirming the deterioration is accelerating at the swing-trade horizon. Advance-decline has been negative four of the last five sessions, and net new highs collapsed from 72 on 4 September to -14 today — the first negative reading in this run. Over the last five days, 63 stocks rotated out of Stage 2 into Stage 3 against only 29 moving the other way, a net loss of 34 advancing names; the Stage-2 cohort has also narrowed by 3.5 over the last 20 days. The trajectory call is range-bound and mixed at best, and the weight of the evidence tilts toward further hollowing out.

Leadership: thin, defensive, and concentrated in small pockets

On the day, Financials led with a 0.3% gain — barely leadership — while Communication Services and Real Estate were flat. Over three months, Real Estate and Consumer Discretionary have been the genuine leaders, but both are well off that pace now. The one sector where the Stage-2 cohort is expanding with any conviction is Energy, where the advancing share has widened meaningfully over the last 20 days; Consumer Staples shows a smaller expansion. Among names that cleared the screen, Fineotex Chemical in Materials stands out for volume — its volume ratio is the highest in the leading-setup list — but with the broader tape producing more new lows than new highs today, the bar for follow-through on any of these setups is materially higher than the scores alone suggest.

Leading Stage-2 setups
StockSectorSetup% 1D
Modison LtdIndustrials10.0+5.0%
Oriental Aromatics LtdMaterials9.8-2.9%
Welspun Enterprises LtdIndustrials9.8+1.9%
AVT Natural Products LtdConsumer Staples9.8-2.0%
Fineotex Chemical LtdMaterials9.8+0.5%
Bliss GVS Pharma LtdHealth Care9.4+1.1%
KRN Heat Exchanger and Refrigeration LtdIndustrials9.4-0.8%
Manaksia Steels LtdMaterials9.4+5.0%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Financials+0.3%-2.8%+1.9%5933%
Communication Services+0.0%-1.1%+8.9%5924%
Real Estate+0.0%-1.0%+12.2%5427%
Consumer Discretionary-0.1%-1.8%+11.4%6035%
Energy-0.2%-2.6%+0.8%5952%
Consumer Staples-0.2%-4.8%-3.5%4335%
Health Care-0.2%+0.9%+10.8%7146%
Information Technology-0.2%-5.6%+4.7%4526%
Materials-0.3%-0.3%+3.3%6436%
Utilities-0.3%-2.6%-5.7%5718%
Industrials-0.4%-0.8%+5.0%6829%
Share of NSE stocks in Stage 2Mar 2026 – Sep 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 34%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →